Prevalence, clearance, and incidence of human papillomavirus type-specific infection at the anal and penile site of HIV-infected men

Sexually Transmitted Diseases

Volumn 40, Issue 8, 2013, Pages 611-618

  Darwich, Laila ^a,b   Cañadas, Mari Paz ^a,c   Videla, Sebastian ^a   Coll, Josep ^a,d   Molina López, Rafael A ^a,b   Sirera, Guillem ^a,e   Clotet, Bonaventura ^a,d,e  

^a Lluita Contra la SIDA Foundation   (Spain)

^b UNIVERSITAT AUTÒNOMA DE BARCELONA   (Spain)

^c SYNLAB ACADEMY   (Germany)

^d IrsiCaixa Foundation   (Spain)

^e HOSPITAL UNIVERSITARI GERMANS TRIAS I PUJOL   (Spain)

Author keywords

[No Author keywords available]

Indexed keywords

ANUS DISEASE; ARTICLE; COHORT ANALYSIS; HETEROSEXUALITY; HIGH RISK PATIENT; HUMAN; HUMAN IMMUNODEFICIENCY VIRUS INFECTION; HUMAN PAPILLOMAVIRUS TYPE 11; HUMAN PAPILLOMAVIRUS TYPE 16; HUMAN PAPILLOMAVIRUS TYPE 18; HUMAN PAPILLOMAVIRUS TYPE 31; HUMAN PAPILLOMAVIRUS TYPE 33; HUMAN PAPILLOMAVIRUS TYPE 35; HUMAN PAPILLOMAVIRUS TYPE 45; HUMAN PAPILLOMAVIRUS TYPE 52; HUMAN PAPILLOMAVIRUS TYPE 58; HUMAN PAPILLOMAVIRUS TYPE 59; HUMAN PAPILLOMAVIRUS TYPE 6; INCIDENCE; MAJOR CLINICAL STUDY; MALE; MEN WHO HAVE SEX WITH MEN; NONHUMAN; PAPILLOMAVIRUS INFECTION; PENIS DISEASE; PREVALENCE; PROSPECTIVE STUDY; VIRAL CLEARANCE; WART VIRUS;

ADULT; ANUS DISEASES; ANUS NEOPLASMS; FEMALE; HETEROSEXUALITY; HIV INFECTIONS; HOMOSEXUALITY, MALE; HUMAN PAPILLOMAVIRUS 16; HUMANS; INCIDENCE; MALE; MASS SCREENING; PAPILLOMAVIRUS INFECTIONS; PENILE DISEASES; PREVALENCE; PROSPECTIVE STUDIES; QUESTIONNAIRES; RISK FACTORS; SEXUAL BEHAVIOR; SPAIN; UTERINE CERVICAL NEOPLASMS;

EID: 84880538351     PISSN: 01485717     EISSN: 15374521     Source Type: Journal    
DOI: 10.1097/01.OLQ.0000430798.61475.08     Document Type: Article

References (29)

1. Vajdic CM, van LeeuwenMT, Jin F, et al. Anal human papillomavirus genotype diversity and co-infection in a community-based sample of homosexual men. Sex Transm Infect 2009; 85:330-335.
2. Pierangeli A, Scagnolari C, Degener AM, et al. Type-specific human papillomavirus-DNA load in anal infection in HIV-positive men. AIDS 2008; 22:1929-1935.
3. de Pokomandy A, Rouleau D, Ghattas G, et al., HIPVIRG Study Group. Prevalence, clearance, and incidence of anal human papillomavirus infection in HIV-infected men: The HIPVIRG cohort study. J Infect Dis 2009; 199:965-973.
4. Bosch FX, de SanJosé S. Chapter 1: Human papillomavirus and cervical cancer-burden and assessment of causality. J Natl Cancer Inst Monogr 2003; 31:3-13.
5. Aboulafia DM, Gibbons R. Penile cancer and human papillomavirus (HPV) in a human immunodeficiency virus (HIV)-infected patient. Cancer Invest 2001; 19:266-272.
6. Grulich AE, van Leeuwen MT, Falster MO, et al. Incidence of cancers in people with HIV/AIDS compared with immunosuppressed transplant recipients: A meta-analysis. Lancet 2007; 370:59-67.
7. Piketty C, Selinger-Leneman H, Grabar S, et al. Marked increase in the incidence of invasive anal cancer among HIV-infected patients despite treatment with combination antiretroviral therapy. AIDS 2008; 22:1203-1211.
8. Mork J, Lie AK, Glattre E, et al. Human papillomavirus infection as a risk factor for squamous cell carcinoma of the head and neck. N Engl J Med 2001; 344:1125-1131.
9. Herrero R, Castellsagué X, Pawlita M, et al., IARC Multicenter Oral Cancer Study Group. Human papillomavirus and oral cancer: The International Agency for Research on Cancer multicenter study. J Natl Cancer Inst 2003; 95:1772-1783.
10. Coutle'e F, Trottier AM, Ghattas G, et al. Risk factors for oral human papillomavirus in adults infected and not infected with human immunodeficiency virus. Sex Transm Dis 1997; 24:23-31.
11. Kreimer AR, Alberg AJ, Daniel R, et al. Oral human papillomavirus infection in adults is associated with sexual behavior and HIV serostatus. J Infect Dis 2004; 189:686-698.
12. Can?adas MP, Bosch FX, Junquera ML, et al. Concordance of prevalence of human papillomavirus DNA in anogenital and oral infections in a high-risk population. J Clin Microbiol 2004; 42:1330-1332.
13. Parisi SG, Cruciani M, Scaggiante R, et al. Anal and oral human papillomavirus (HPV) infection in HIV-infected subjects in northern Italy:A longitudinal cohort study among men who have sex withmen. BMC Infect Dis 2011; 11:150.
14. Videla S, Darwich L, Can?adas MP, et al., HIV-HPV Can Ruti Study Group. Natural history of human papillomavirus infections involving anal, penile, and oral sites among HIV-positive men. Sex Transm Dis 2013; 40:3-10.
15. Can?adas P, Darwich L, Videla S, et al. Circumcision and penile HPV prevalence in HIV-infected men: Heterosexual and men who have sex with men. Clin Microbiol Infect 2013; 19:611-616.
16. Darwich L, Can?adas MP, Videla S, et al. Condylomata, cytological abnormalities and human papillomavirus infection in the anal canal in HIV-infected men. HIV Med 2012; 13:549-557.
17. Kellokoski J, Syrja?nen S, -liskoski M, et al. Dot blot hybridization in detection of human papillomavirus (HPV) infections in the oral cavity of women with genital HPV infections. Oral Microbiol Immunol 1992; 7:19-23.
18. Kreimer AR, Villa A, Nyitray AG, et al. The epidemiology of oral HPV infection among a multinational sample of healthy men. Cancer Epidemiol Biomarkers Prev 2011; 20:172-182.
19. Dietz CA, Nyberg CR. Genital, oral, and anal human papillomavirus infection inmenwho have sexwithmen. JAmOsteopath Assoc 2011; 111:S19-S25.
20. Goodman MT, Shvetsov -B, McDuffie K, et al. Sequential acquisition of human papillomavirus (HPV) infection of the anus and cervix: The Hawaii HPV CohortStudy. J Infect Dis 2010; 201:1331-1339.
21. Nyitray AG, Carvalho da Silva RJ, Baggio ML, et al. Six-month incidence, persistence, and factors associated with persistence of anal human papillomavirus in men: The HPV in men study. J Infect Dis 2011; 204:1711-1722.
22. OrlandoG, Tanzi E, Beretta R, et al. Human papillomavirus genotypes and anal-related lesions among HIV-1-infected men in Milan, Italy. J Acquir Immune Defic Syndr 2008; 47:129-131.
23. Nyitray AG, Smith D, Villa L, et al. Prevalence of and risk factors for anal human papillomavirus infection in men who have sex with women: A cross-national study. J Infect Dis 2010; 201:1498-1508.
24. Giuliano AR, Anic G, Nyitray AG. Epidemiology and pathology of HPV disease in males. Gynecol Oncol 2010; 117:S15-S19.
25. Silva RJ, Casseb J, Andreoli MA, et al. Persistence and clearance of HPV from the penis of men infected and non-infected with HIV. J Med Virol 2011; 83:127-131.28.
26. Mbulawa ZZ, Coetzee D, Marais DJ, et al. Genital human papillomavirus prevalence and human papillomavirus concordance in heterosexual couples are positively associated with human immunodeficiency virus coinfection. J Infect Dis 2009; 199:1514-1524.
27. Giuliano AR, Lee JH, Fulp W, et al. Incidence and clearance of genital human papillomavirus infection in men (HIM): A cohort study. Lancet 2011; 377:932-940.
28. Morris BJ, Gray RH, Castellsague X, et al. The strong protective effect of circumcision against cancer of the penis. Adv Urol 2011; 2011:812368.
29. Nielson CM, Schiaffino MK, Dunne EF, et al. Associations between male anogenital human papillomavirus infection and circumcision by anatomic site sampled and lifetime number of female sex partners. J Infect Dis 2009; 199:7-13.